EKOS Corporation is the world leader in providing ultrasound-assisted, fluid infusion catheters for treating blood clots. Other applications which deliver physician-prescribed fluids or contrast agent to other targeted locations in the body are under investigation.
Employees: 201-500
Total raised: $22.5M
Founded date: 2005
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.01.2009 | - | $12.5M | - |
| 05.06.2007 | - | $10M | - |
Mentions in press and media 6
| Date | Title | Description |
| 17.10.2019 | Ekos announces $8M Series A to build software for craft breweries | Ekos, a Charlotte, N.C. startup that creates software to help craft breweries and other beverage companies organize their businesses, announced an $8 million Series A today led by Noro-Moseley Partners, an Atlanta venture firm. Prior to tak... |
| 17.10.2019 | Ekos Announces $8M Series A To Build Software for Craft Breweries | - |
| 17.10.2019 | Ekos Secures $8M in Series A Funding | Ekos, a Charlotte, N.C.-based provider of business management software for independent craft beverage companies, secured an $8m Series A funding round. The round was led by Noro-Moseley Partners. Alan Taetle, General Partner, and John Ale, ... |
| 30.01.2009 | Ekos, Maker of Ultrasound Clot Dissolver, Raises $12.5 Million for Commercial Push | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Ekos has been working for more than a decade on a miniature ultrasound probe that slithers inside leg veins, and gently amplifies the effect of drugs that dissolve blood clots... |
| 28.03.2008 | Life-science briefing: Friday, March 28, 2008 | VaxGen, Raven Bio terminate merger agreement — A weirdly structured, always hard-to-understand merger between the failed vaccine biotech VaxGen and startup Raven Biotechnologies has collapsed. The two companies called off the combination af... |
| 05.06.2007 | Ultrasound clot-buster Ekos raises $10M in debt | Ekos, a Bothell, Wash., maker of ultrasound-enhanced drug-delivery systems, raised $10 million in debt capital from Hercules Technology Growth Capital. The financing will support the sales and marketing of drug-delivery catheters that featu... |